A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients
Clinical trial NCT01199939 · COMPLETED
Trial details
- NCT number
- NCT01199939
- Sponsor
- Tibotec, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2012-10-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.